Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Possibility for error in FDA diffusion assays.

M A Foglesong, F Kavanagh, J V Dietz

    Journal of Pharmaceutical Sciences
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Action of forty-five antibacterial substances on bacterial viruses.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Chemical determination of pleurotin, an antibacterial substance from Pleurotus griseus.

    Archives of biochemistry·2010
    Same author

    Learning styles of deaf college students and instructors' teaching emphases.

    Journal of deaf studies and deaf education·2004
    Same author

    Alberta RN on-line.

    Alberta RN·2002
    Same author

    The influence of genetic counselling in the era of DNA testing on knowledge, reproductive intentions and psychological wellbeing.

    Clinical genetics·1994
    Same author

    Wiley Award address. Theory and practice of microbiological assaying for antibiotics.

    Journal - Association of Official Analytical Chemists·1989

    An error in antibiotic diffusion assays can be avoided by consistently correcting standard and sample plate responses. This ensures accurate estimation of antibiotic potency in samples.

    Area of Science:

    • Microbiology
    • Pharmaceutical Science
    • Analytical Chemistry

    Background:

    • The US Food and Drug Administration (FDA) single-dose diffusion assay is a standard method for determining antibiotic potency.
    • Current computational procedures in this assay may introduce significant errors in potency estimations.
    • An unrecognized error in reference solution concentration has been identified as a primary source of inaccuracy.

    Purpose of the Study:

    • To identify and explain the source of error in the FDA single-dose diffusion assay for antibiotics.
    • To propose a correction method to improve the accuracy of antibiotic potency estimation.
    • To ensure reliable results in antibiotic susceptibility testing and drug development.

    Main Methods:

    • Analysis of computational procedures used in the FDA single-dose diffusion assay.

    Related Experiment Videos

  • Identification of the discrepancy in correcting responses from standard and sample plates.
  • Development of a revised correction method for assay data.

    • Main Results:

    • A significant error in estimated sample potency arises from differential correction of standard and sample plate responses.
    • The error is directly linked to the concentration of the reference solution used.
    • A revised method involving consistent correction of both standard and sample responses to the observed reference response eliminates the identified error.

    Conclusions:

    • The differential correction of responses in the FDA antibiotic diffusion assay leads to substantial errors in potency estimation.
    • Correcting both standard and sample responses to the observed reference response is a crucial modification for accurate results.
    • Implementing this correction method will enhance the reliability of antibiotic potency assays in pharmaceutical analysis and quality control.